# Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects

> **NCT05304845** · PHASE1 · COMPLETED · sponsor: **Daewoong Pharmaceutical Co. LTD.** · enrollment: 24 (actual)

## Conditions studied

- Drug Drug Interaction

## Interventions

- **DRUG:** DWP14012
- **DRUG:** Aspirin

## Key facts

- **NCT ID:** NCT05304845
- **Lead sponsor:** Daewoong Pharmaceutical Co. LTD.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-03-21
- **Primary completion:** 2022-05-22
- **Final completion:** 2022-05-22
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2023-04-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05304845

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05304845, "Drug-drug Interactions Between DWP14012 and Aspirin in Healthy Subjects". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT05304845. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*